AR229346A1 - Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada - Google Patents

Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada

Info

Publication number
AR229346A1
AR229346A1 AR279420A AR27942079A AR229346A1 AR 229346 A1 AR229346 A1 AR 229346A1 AR 279420 A AR279420 A AR 279420A AR 27942079 A AR27942079 A AR 27942079A AR 229346 A1 AR229346 A1 AR 229346A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
oral use
programmed release
use medicines
Prior art date
Application number
AR279420A
Other languages
English (en)
Original Assignee
Panoz Donald E
Corneille Gilbert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7836084A external-priority patent/FR2444460A1/fr
Priority claimed from FR7908180A external-priority patent/FR2452922A2/fr
Priority claimed from FR7908181A external-priority patent/FR2452923A2/fr
Priority claimed from FR7930041A external-priority patent/FR2470600A2/fr
Application filed by Panoz Donald E, Corneille Gilbert filed Critical Panoz Donald E
Application granted granted Critical
Publication of AR229346A1 publication Critical patent/AR229346A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
AR279420A 1978-12-22 1979-12-21 Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada AR229346A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7836084A FR2444460A1 (fr) 1978-12-22 1978-12-22 Nouvelle forme galenique a usage oral, et son procede de preparation
FR7908180A FR2452922A2 (fr) 1979-04-02 1979-04-02 Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR7908181A FR2452923A2 (fr) 1979-04-02 1979-04-02 Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR7930041A FR2470600A2 (fr) 1979-12-07 1979-12-07 Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee

Publications (1)

Publication Number Publication Date
AR229346A1 true AR229346A1 (es) 1983-07-29

Family

ID=27446389

Family Applications (1)

Application Number Title Priority Date Filing Date
AR279420A AR229346A1 (es) 1978-12-22 1979-12-21 Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada

Country Status (9)

Country Link
US (2) US4609542A (es)
AR (1) AR229346A1 (es)
AT (1) AT376567B (es)
CH (1) CH647676A5 (es)
DE (1) DE2950977A1 (es)
ES (1) ES487151A1 (es)
GB (1) GB2039737B (es)
IE (1) IE48715B1 (es)
IT (1) IT1164548B (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
IT1204839B (it) * 1986-03-14 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ242806A (en) * 1991-05-20 1994-01-26 Marion Laboratories Inc Multi-layered acid-containing coated drug beads.
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2733423B1 (fr) * 1995-04-26 1997-06-20 Virbac Lab Compositions pulverulentes et solubles dans l'eau et leurs applications
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US6596307B1 (en) * 1999-06-15 2003-07-22 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
JP3893058B2 (ja) * 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー 高度に可溶性の薬物のための徐放性マトリックス系
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
KR100968128B1 (ko) 2000-10-30 2010-07-06 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
ES2550035T3 (es) * 2006-01-27 2015-11-04 Adare Pharmaceuticals, Inc. Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
CN101410093A (zh) * 2006-01-27 2009-04-15 欧兰德股份有限公司 包含弱碱性药物和有机酸的药物递送系统
JP2008534681A (ja) * 2006-02-09 2008-08-28 テバ ファーマシューティカル インダストリーズ リミティド ジピリダモール持続放出製剤及びそれを調製のための方法
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
EP2051696A2 (en) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
JP2012502015A (ja) * 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ 必要がある患者に医薬組成物を送達するための方法
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2010151697A1 (en) * 2009-06-25 2010-12-29 Pozen Inc. Method for treating a patient in need of aspirin therapy
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US3044938A (en) * 1955-07-01 1962-07-17 Sandoz Chemical Works Inc Sustained action pharmaceutical tablets
GB785262A (en) * 1955-09-23 1957-10-23 Smith Kline & French Internat Improvements in or relating to hypotensive and sedative preparations
US2809918A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
US2809917A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical tablets
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US2897122A (en) * 1956-10-04 1959-07-28 Frosst & Co Charles E Enteric coated product
GB831907A (en) * 1957-09-12 1960-04-06 Organon Labor Ltd Suspensions of drugs destined for injection and process for the preparation thereof
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations
NL109170C (es) * 1958-02-03
DE1248863B (es) * 1959-01-30
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US2993837A (en) * 1959-07-13 1961-07-25 Frosst & Co Charles E Enteric coated tablets
US3081233A (en) * 1960-08-08 1963-03-12 Upjohn Co Enteric-coated pilules
NL122039C (es) * 1960-10-20
US3102845A (en) * 1960-11-18 1963-09-03 Mcneilab Inc Pharmaceutical tablet
US3166476A (en) * 1961-09-01 1965-01-19 Lowey Hans Powder based tablets
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
NL297631A (es) * 1963-06-03
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
CH521313A (de) * 1969-05-14 1972-04-15 Hoffmann La Roche Verfahren zur Herstellung von Phenylalaminderivaten
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet
DE2010116A1 (de) * 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrogranulaten
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US4025613A (en) * 1971-07-19 1977-05-24 Richard G. Powers Timed-release aspirin
US3828106A (en) * 1972-01-03 1974-08-06 Biolog Concepts Inc Novel oral pharmaceutical dosage form
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1367608A (en) * 1973-03-09 1974-09-18 Biolog Concepts Inc Oral pharmaceutical dosage form
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
GB1422176A (en) * 1973-05-05 1976-01-21 Beecham Group Ltd Pharmaceutical tablets
US4113816A (en) * 1973-07-12 1978-09-12 Choay S.A. Process for the manufacture of layered tablets incorporating controlled-release microcapsules
US3961004A (en) * 1974-04-11 1976-06-01 Auburn Research Foundation Method of tabletting using gluconolactone as the direct compression diluent
GB1551954A (en) * 1975-05-28 1979-09-05 Hoffmann La Roche Standardization of a physiochemical parameter of a batch of formulation in tabletted form
US4016744A (en) * 1975-05-28 1977-04-12 Hoffmann-La Roche Inc. Applied instrumentation providing tabletting compression force
FR2353285A1 (fr) * 1975-09-17 1977-12-30 Doms Laboratoires Medicament vasodilatateur coronarien perfectionne
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
FR2368272A1 (fr) * 1976-10-20 1978-05-19 Theramex Compositions therapeutiques solides pour combattre l'agregation plaquettaire
LU77353A1 (es) * 1977-05-16 1979-01-19
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Also Published As

Publication number Publication date
US4609542A (en) 1986-09-02
DE2950977A1 (de) 1980-07-10
IT1164548B (it) 1987-04-15
ES487151A1 (es) 1980-09-16
ATA808179A (de) 1984-05-15
IT7928301A0 (it) 1979-12-21
AT376567B (de) 1984-12-10
IE792452L (en) 1980-06-22
IE48715B1 (en) 1985-05-01
GB2039737A (en) 1980-08-20
DE2950977C2 (es) 1987-11-05
CH647676A5 (fr) 1985-02-15
US4726951A (en) 1988-02-23
GB2039737B (en) 1983-07-20

Similar Documents

Publication Publication Date Title
AR229346A1 (es) Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada
ES498055A0 (es) Un procedimiento para la preparacion de una piridilanilina
MX156495A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
MX161165A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
ES490018A0 (es) Un procedimiento para la preparacion de una nueva composi- cion de copolieterester.
ES497470A0 (es) Un procedimiento para la preparacion de una composicion blanqueadora.
ES533263A0 (es) Procedimiento para la preparacion de una vacuna neumococcica multivalente.
ES503011A0 (es) Un procedimiento para la preparacion de una formulacion por-tadora de farmacos,biodegradable y magneticamente localiza- ble
MX160752A (es) Mejoras a procedimiento para preparar una composicion de arcilla organofilica
AR222624A1 (es) Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada
ES486157A0 (es) Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina
ES504905A0 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
ES519871A0 (es) Procedimiento para preparar una composicion superplastificante de cemento.
ES519237A0 (es) Procedimiento de preparacion de una composicion tintorea para cabellos.
ES487319A0 (es) Procedimiento para la preparacion de una composicion de cau-cho vulcanizada
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
ES484916A0 (es) Un procedimiento para la preparacion de una composicion ter-moplastica.
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
MX5976E (es) Procedimiento mejorado para preparar una composicion farmaceutica a partir de cefalexina
ES491517A0 (es) Procedimiento para preparar una vacuna de virus de gripe
ES525806A0 (es) Un procedimiento para la preparacion de una composicion refractaria de circonio.
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
MX157168A (es) Mejoras a procedimiento para preparar una pasta dental
MX7581E (es) Procedimiento para preparar una composicion farmaceutica a base de famotidina
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica